Christopher Lewis

Christopher Lewis has a diverse work experience in the fields of biopharmaceuticals and biomedical research. Christopher currently holds the position of Scientist II / Project Lead at KBI Biopharma, where they have been working since June 2021. Prior to this, they worked as a Scientist I at the same company from June 2019 to May 2021.

Before joining KBI Biopharma, Christopher worked as a Graduate Student at the University of Oklahoma from July 2011 to August 2018. During this time, they conducted research in microfluidics for biomedical applications, focusing on the effect of high shear exposure on neutrophils and platelets. Christopher also developed a microfluidic device for evaluating cell adhesion and rolling.

Christopher's work experience also includes a role as an Undergraduate Researcher at UC Berkeley from February 2010 to May 2011. In this position, they conducted research on ribosomes in protein biosynthesis and gained skills in molecular biology techniques. Christopher also had an internship at NovaBay Pharmaceuticals in the formulations department, where they worked on experiments related to gel formulations and drug compatibility.

Overall, Christopher has a strong background in scientific research and project leadership, with expertise in biopharmaceuticals, microfluidics, and molecular biology techniques.

Christopher Lewis received their Bachelor of Science degree in Chemical and Biomolecular Engineering from the University of California, Berkeley in 2011. Christopher went on to pursue a Doctor of Philosophy degree in Chemical Engineering at the University of Oklahoma from 2011 to 2018.